I still think it was a dick move for Dan to make Vinny bomb the runway for no reason. He was the one who presented this as a competition and yet he straight up sabotaged Vinny's run. It certainly made for an entertaining video so I guess I should be thanking him. Keep up the great work @turboman.
How exactly was it Dan's fault that Vinny randomly picked "blow up the runway" as his wild card. It could have easily been one of the other guys to pick it out of the bucket.
Well, Vinny HAD already done that by throwing the proximity mine downstairs earlier. But really, a "dick move"? Do you honestly think that in his heart of hearts Vinny would have rather completed everything than drop a lighting rig on a fashion show?
Good write up. The thing is, I still don't think that Hitman nescisarrily is setting a great example for how episodic games should be handled. I feel like when anyone talks about this Hitman, the episodic release is always first and foremost what is addressed, but there is one point that I don't really feel gets enough attention: this game is freaking AWESOME! If it wasn't fun to play, the episodic nature would have killed the game and kicked its corpse. I like the TellTale games a lot, but don't ever play them until the full season is out, namely because they aren't very fun to actually play. The stories are good and I love seeing my decisions spiraling out in ways that I never predicted, but none of them have been what I would refer to as "fun." If anything, I feel like Hitman's episodic schedule served IO best by allowing them to put out a game with as limited number of levels as this one had. Don't get me wrong, this game is by no means lacking in content, from escalations to elusive targets to all of the challenges. But if this game had come out all at one time, people would surely have criticized the game for featuring a fraction of the levels that are normally present in a Hitman game. All in all, I'm not entirely sure that other games really have very much to learn from the success of Hitman, other than its possible to make it work. But you better make damn sure your game is engaging, silly, fun to play and heart pounding first, before you start worrying about how to handle an episodic release. Wow, that is some disjointed rambling right there sorry yall, I'm not nearly as good a writer as Janine!
I'm pretty sure they pass the place Dan was looking for at around 29:25.
I haven't live in Lawrence for about 8 years, but they weren't even on the right street for the Outhouse. Its 15th street out of town, and they took 11th. The road they were on curves to the right a little further from where they stopped, then it intersects with the road the Outhouse is actually on. Not sure how Dan wouldn't remember you had to go past the cemetery to get there
@brad: great to hear you are enjoying it in your own time! Boy do i ever hope to hear your patented arguing skills during GOTY to get this game some of the love it deserves. Still holding out hope for a video of the night Marakkesh mission from the Summer bonus. I need hitman in my veins!
Hope in this one there isn't just a set of souls/moves that just win the game for you at some point. Even though they fixed a lot of the combos in the first one, turning Super Saiyan then doing whatever that huge green energy disc move from one of the androids just devastated anything that moved.
@cornfed40: When I say it's broken, I'm not referring to the concept of patents just clear implementations. You list plant variety specifically, but the exact same problem happens in pharmaceutical patents. Thing is those patents expire for a reason and that's to stop monopolizing of certain innovations. That's why they have expirations at all. Pharma would take a hit, but they're not going to stop producing medicine and more innovations. Quite the contrary actually, since they can't essentially sit on their patents and create new ways or essentially renewing the same patents, they will be forced to actually innovate as well as sell their current products that have reached their expiration more competitively. Therefore they will be forced more than ever to actually make new discoveries in medicine and it would still be in their best interest to do so. Those companies still created their business on pharmaceuticals and the patents would still give them a clear and distinct advantage to being the first. It wouldn't turn into the wild west where all progress is abandoned in the hopes of a quick buck in a lawless land. The same regulations and patents would still be in place only this time they would be temporary as they were intended. It only makes clear and distinct advantages less permanent and stops the attempted prevention of innovation by outside companies. It would be a net positive and truly is no different than plant variety patents. After all, your same argument that Big Pharma would simply give up their potential sales would be the exact same argument for Monsanto and other large farming business.
Not really, I think you are misunderstanding what a plant variety patent is. In the present example of, say, Monsanto Roundup Ready soybeans. Monsanto received a utility (trait) patent for the genetic modification which makes soybeans resistant to the Roundup pesticide. Like all utility patents, that one had a life of 20 years. These are the same kinds of patents pharmaceutical company receive to protect their proprietary drugs for 20 years until the patent expires, allowing generic version to flood the market. That original patent is now expired. So, technically, the Roundup ready gene for soybeans should be available for anyone use in their own products (beans in this example). However, another kind of patent exists, the plant variety patent. These patents allow the applicant 20 years of protection for any unique variety of a plant or seed which they are able to develop. This does not exist for any industry other than plants. Genetic traits are astoundingly difficult and complex things. So, even if the genetric trait patent expires in 2016, a plant variety patent which was obtained last year for a Roundup ready soybean would be good until ~2035. The seed companies control what seed is available for purchase, so as long as the do not sell a protected variety less than one year before its protection ends, the possibility of reverse engineering or creating a generic "knock off" version does not exist without falling under the umbrella of "patent infringement." Also, Monsanto does continue to make their products better and innovate, as they also have a patent on their RoundUp Ready 2 genetic trait, which is even more resistant and therefor, they have come up with even deadlier pesticides, which will force the original Roundup read beans out of the market before a generic would even be a factor. So a company like Monsanto, even more so than a pharmaceutical company, can create a circle of patent protection that can never be broken. That's why my problem lies not so much with patents in general, but plant variety patents specifically.
cornfed40's comments